Theravance Biopharma Cash from Investing (TTM) Trends

Theravance Biopharma Inc (TBPH)

9.215 -0.24 (-2.59%) USD | NASDAQ | Apr 23, 16:00

9.215 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-32.70M
September 30, 2023	7.141M
June 30, 2023	1.083B
March 31, 2023	1.079B
December 31, 2022	1.154B
September 30, 2022	1.126B
June 30, 2022	14.47M
March 31, 2022	42.72M
December 31, 2021	124.49M
September 30, 2021	166.04M
June 30, 2021	268.37M
March 31, 2021	56.02M
December 31, 2020	10.72M
September 30, 2020	-27.59M
June 30, 2020	-117.78M
March 31, 2020	57.51M
December 31, 2019	-83.05M
September 30, 2019	2.281M
June 30, 2019	72.58M
March 31, 2019	115.84M
December 31, 2018	176.71M

Date	Value
September 30, 2018	118.56M
June 30, 2018	86.68M
March 31, 2018	55.90M
December 31, 2017	-56.33M
September 30, 2017	-143.79M
June 30, 2017	-208.39M
March 31, 2017	-288.14M
December 31, 2016	-148.24M
September 30, 2016	-136.53M
June 30, 2016	-24.60M
March 31, 2016	85.27M
December 31, 2015	111.04M
September 30, 2015	155.23M
June 30, 2015	-16.72M
March 31, 2015	-62.48M
December 31, 2014	-106.25M
September 30, 2014	-117.00M
June 30, 2014	-7.382M
March 31, 2014	-3.614M
December 31, 2013	-2.634M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-117.78M

Minimum

Jun 2020

1.154B

Maximum

Dec 2022

263.29M

Average

56.02M

Median

Mar 2021

Cash from Investing (TTM) Benchmarks